Can flunarizine be used for migraine prophylaxis in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flunarizine for Migraine Prophylaxis in Children

Flunarizine is an effective second-line medication for migraine prophylaxis in children and can be safely used in pediatric populations. 1, 2

Efficacy and Positioning in Treatment Algorithm

  • Flunarizine (10 mg/day) is considered a second-line medication for migraine prophylaxis after first-line options (beta blockers, topiramate, and candesartan) have been tried 1
  • Clinical trials demonstrate that flunarizine significantly reduces both the frequency and average duration of headache attacks in children 3
  • In comparative studies, flunarizine has shown effectiveness comparable to other prophylactic medications used in pediatric migraine, including propranolol, topiramate, and cyproheptadine 2

Dosing in Children

  • For children, the recommended starting dose is 5 mg daily 4, 3
  • The dose may be increased to 10 mg daily if there is inadequate response after 2-4 weeks of treatment 4
  • Clinical improvement is typically observed between 2-4 weeks after initiating treatment 4

Evidence of Effectiveness

  • Double-blind, placebo-controlled studies have shown that flunarizine (5 mg/day) significantly reduces both frequency and duration of migraine attacks in children 3
  • A systematic review with meta-analysis confirmed that flunarizine is effective for episodic migraine prophylaxis, supporting guideline recommendations 5
  • A recent study (2022) demonstrated that flunarizine significantly reduced Pediatric Migraine Disability Assessment Scores (PedMIDAS) in children with migraine 2

Side Effects and Monitoring

  • The most common side effects of flunarizine in children include:
    • Daytime sedation/drowsiness 3
    • Weight gain 5, 3
  • Less common but important side effects to monitor:
    • Depression (particularly in older patients) 1
    • Extrapyramidal symptoms (more common in elderly patients but should be monitored in all age groups) 1

When to Consider Prophylaxis

  • Migraine prophylaxis should be considered in children when:
    • Symptoms cause frequent school absenteeism 2
    • Quality of life is significantly impaired 2
    • There are recurring emergency room visits 2
    • Frequent analgesic use raises concerns about medication overuse headache 2
    • Patients are adversely affected by migraine on ≥2 days per month despite optimized acute treatment 1

Treatment Algorithm for Pediatric Migraine Prophylaxis

  1. Start with first-line agents:

    • Beta blockers (propranolol) 1, 6
    • Topiramate (in children >6 years) 6
    • Candesartan (in older children) 1
  2. If first-line agents fail or are contraindicated, consider second-line options:

    • Flunarizine 1, 2
    • Amitriptyline (not recommended in children under 6 years) 6, 7
  3. For children under 6 years:

    • Non-pharmacological approaches should be prioritized 6
    • If medication is absolutely necessary, propranolol is preferred 6
    • Flunarizine may be considered when other options have failed 4, 3

Practical Considerations

  • Treatment duration should typically be at least 3-6 months before evaluating full efficacy 3
  • Regular follow-up is essential to monitor for side effects and assess treatment response 2
  • Consider discontinuing treatment after a period of stability to determine if prophylaxis is still needed 1
  • Avoid medication overuse of acute treatments during prophylactic therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effects and side effects of migraine prophylaxis in children.

Pediatrics international : official journal of the Japan Pediatric Society, 2022

Research

Flunarizine for prophylactic treatment of childhood migraine.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2004

Guideline

Migraine Prophylaxis in Children Under 6 Years

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pediatric migraine: pharmacologic agents for prophylaxis.

The Annals of pharmacotherapy, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.